Our mission is to guide and inspire research and scholarship in pharmacoepidemiology and drug safety.
Our vision is to improve public health by enhancing the safety of marketed medications through the development and application of pharmacoepidemiology and pharmacovigilance research and to provide education on approaches to identify, assess, manage and minimize risk.
Strategic Goals
- Develop and assess new methods for population-based monitoring of drugs and biologicals
- Foster collaborations with public and private stakeholders, including academia, government, industry, advocacy and consulting groups, through a culture of cooperation and critical review
- Provide graduate and continuing professional education on drug safety and pharmacovigilance
- Expand the pool of experts in pharmacoepidemiology and drug safety research through the training of new researchers
- Disseminate new approaches to drug safety and risk management to inform policy and practice
Recent News
Zuckerman Teaches in Thailand
Ilene Zuckerman, Chair of PHSR Department, recently spent three months as a Fulbright Scholar and Visiting Professor at Chulalongkorn University Faculty of Pharmacy in Bangkok, Thailand. Under this program, she provided assistance with educational activities for PhD students in the areas of drug utilization and pharmacoepidemiology.
In addition, she worked with Thai Food and Drug Administration (Thai FDA) staff and with faculty at Chulalongkorn University to develop a national database for assessing drug use patterns. She also gave talks on pharmacoepidemiology at other Faculties of Pharmacy across Thailand and in Malaysia.
This project is an incremental step in building a research agenda that examines factors that affect medication use in Thailand. Dr. Zuckerman will continue to collaborate with Chulalongkorn University faculty and Thai FDA staff to study drug use and safety.
Chen Gives Talk On Stevens Johnson Syndrome
The Center for Drug Safety held its first sponsored lecture on Wednesday, March 25, 2009 in the School of Nursing Auditorium. Dr YT Chen from Duke University and Academia Sinica (Taiwan) spoke about his lab work into the genetics of Stevens Johnson Syndrome. It was a great talk on translational medicine - from the discovery of a gene, to the epidemiology, and to regulatory/labeling changes.
Weiss Appointed As Center Director
Sheila Weiss Smith, PhD, a professor of pharmaceutical health services research, has been appointed as director of the Center for Drug Safety, Department of Pharmaceutical Health Services Research (PHSR), School of Pharmacy. The center’s mission is to guide and inspire research and scholarship in pharmacoepidemiology and drug safety.